NEUCA S.A. (WSE:NEU)

Market Cap	3.24B
Revenue (ttm)	12.61B
Net Income (ttm)	154.24M
Shares Out	4.47M
EPS (ttm)	34.01
PE Ratio	21.35
Forward PE	15.52
Dividend	14.50 (2.00%)
Ex-Dividend Date	Jun 12, 2024

Volume	1,242
Average Volume	1,097
Open	719.00
Previous Close	718.00
Day's Range	719.00 - 740.00
52-Week Range	636.00 - 969.00
Beta	0.56
RSI	50.75
Earnings Date	May 18, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,633
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.